
Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.
Donald Tucker has joined DocuSign to help run its corporate development and venture investments.
The offering would produce $500m, including up to $70.6m from the sale of new shares, and offer exits to Max Group and TVS.
SoftBank and Heritage Provider Network were among the investors who co-led a series C round for Intervenn Biosciences, which is developing precision medicine.
Corporate-backed teleconferencing system provider Baijiayun raised cash at a $465m valuation while financial software provider Prime Trust closed a $64m round featuring Nationwide and Samsung Next.
UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.
SoftBank’s Vision Fund returned for the $1bn funding round that valued the personal services platform operator at $15bn.
Mitsui and Nan Fung are among the backers celebrating Rallybio’s flotation on the Nasdaq Global Select Market following an $80.6m offering.
The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.
The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.